by Paul Krzyzanowski | Nov 21, 2012
While the 2012 US election was in full swing, I reminded readers that despite the dominance of the world’s economic problems in this cycle, stem cell research was a political issue that hadn’t completely gone away.[pullquote]Ironically, if – and this is a...
by Nick Dragojlovic | Nov 8, 2012
If you’ve been feeling like you can’t open a web browser these days without finding a story about induced pluripotent stem cells (iPSCs), you’re not alone. Unlike embryonic stem cells, iPSCs are created by directly reprogramming adult cells taken from donors or...
by Paul Krzyzanowski | Sep 20, 2012
[pullquote]How will Romney’s opinion change in light of papers, which describe healthy mice being created from iPS cells?[/pullquote]As 2012 slowly creeps on we can finally see November’s Presidential Election in the United States on the horizon marking the end of a...
by Lisa Willemse | Sep 6, 2012
It seems to me that the number of media stories on stem cell clinical trials (not just preclinical work) is on the increase. Take, for example, news last month of a new clinical trial to test cord blood stem cells as a treatment for autism. This particular...
by Angela C. H. McDonald | Jun 26, 2012
Hiromitsu Nakauchi has a vision for regenerative medicine. In this vision, he sees a renewable source of human organs for transplantation that are grown within the bodies of farm animals. Here’s how it works: pluripotent stem cells would be injected into an early...
by Ubaka Ogbogu | May 18, 2012
The Federal Government has proposed amendments to the Assisted Human Reproduction Act, the legislation that governs embryo research, including many aspects of stem cell research. The amendments, which are contained in an omnibus budget implementation bill tabled...
Comments